[
  {
      "Company": "Fluxion Biosciences",
      "Model": "BioFlux Vascular Shear & Inflammation Model",
      "Organs/Tissues": "Endothelial monolayer under controlled shear flow",
      "Physiological/Pathological": "Artery or venous-like shear conditions, modeling leukocyte rolling/adhesion in inflammation",
      "Cell Source": "Primary human endothelial cells (HUVEC or microvascular) or lines, plus perfused immune cells",
      "Multiple Cell Types": "Yes if including circulating leukocytes; endothelium forms 2D barrier",
      "Stromal Cells": "No (usually not included in standard assay)",
      "Tissue-resident Immune": "No",
      "Circulating Immune": "Yes (perfused WBCs to study adhesion/transmigration)",
      "Crosstalk (Multi-tissue)": "No (single flow channel with endothelium)",
      "Air-Liquid Interface": "No",
      "Extracellular Matrix": "Endothelium adheres to channel coating (e.g. collagen, fibronectin)",
      "3D Scaffold": "No, 2D cell monolayer on channel surface",
      "Notable Features": "Shear flow up to arterial rates, real-time imaging of rolling/adhesion, user-defined flow profiles",
      "Plate/Format (Throughput)": "BioFlux plates: up to 24–48 channels per plate, medium throughput",
      "Max Culture Duration": "Hours–days for continuous flow assays (longer if carefully maintained)",
      "Readouts - Live Imaging": "Yes, microscopy of leukocyte-endothelium interactions, rolling velocities",
      "Readouts - Supernatant Sampling": "Yes, from outlet wells for cytokines",
      "Readouts - Cell Retrieval": "Possible, though limited yields from channel scraping",
      "Readouts - Whole Tissue": "In situ staining/imaging of the monolayer, no bulk tissue",
      "Readouts - TEER": "No integrated electrodes, typically measure function by morphological endpoints",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "No built-in, rely on imaging metrics",
      "Dead Volume": "Low microfluidic channel volume (~100–200 µL total)",
      "Perfused": "Yes, pneumatic or pump-driven flow at controlled shear",
      "Gas Mix Controlled": "Incubator or on-stage warming with optional dual gas input",
      "Real-time Microenvironment Control": "Flow rate, solution switching, drug or cell bolus introduction in real time",
      "model_availability": "Commercial product (BioFlux system), user-run assays"
    },
    {
      "Company": "Fluxion Biosciences",
      "Model": "BioFlux Thrombosis Model (Platelet Aggregation Under Flow)",
      "Organs/Tissues": "Simulated injured vessel surface + flowing whole blood",
      "Physiological/Pathological": "Studies platelet adhesion, activation, clot formation under shear (thrombosis)",
      "Cell Source": "Human blood (fresh or anticoagulated), channel coated with collagen or TF",
      "Multiple Cell Types": "Platelets + WBCs in blood; no tissue co-culture",
      "Stromal Cells": "No",
      "Tissue-resident Immune": "No",
      "Circulating Immune": "Yes (WBCs in the blood sample), though focus is on platelets",
      "Crosstalk (Multi-tissue)": "No, single flow channel simulating vascular injury",
      "Air-Liquid Interface": "No, fully liquid flow",
      "Extracellular Matrix": "Coated channel surfaces mimic subendothelial matrix (collagen, vWF)",
      "3D Scaffold": "No, 2D surface but 3D flow environment",
      "Notable Features": "Real-time platelet aggregation imaging under physiologic shear rates, drug testing (aspirin, etc.)",
      "Plate/Format (Throughput)": "BioFlux plates (24–48 channels), moderate throughput",
      "Max Culture Duration": "Typically short (minutes–hours) as blood is perfused",
      "Readouts - Live Imaging": "Yes, measure platelet adhesion, clot size in real-time",
      "Readouts - Supernatant Sampling": "Possible but less common, usually end readout is imaging-based",
      "Readouts - Cell Retrieval": "Potentially limited, can flush out RBCs/WBCs post-clot",
      "Readouts - Whole Tissue": "N/A, no tissue, just clot on channel",
      "Readouts - TEER": "No",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "No built-in, rely on optical imaging quantification",
      "Dead Volume": "Low channel volume, ~100 µL",
      "Perfused": "Yes, controlling shear up to arterial levels",
      "Gas Mix Controlled": "Incubator or stage-top environment, minimal O₂/CO₂ needs",
      "Real-time Microenvironment Control": "Flow rates, drug addition, pulsatile or steady flow",
      "model_availability": "Commercial product (BioFlux), standard assay for thrombosis"
    },
    {
      "Company": "Fluxion Biosciences",
      "Model": "BioFlux Host–Pathogen & Biofilm Model",
      "Organs/Tissues": "Mammalian cell layer (e.g. oral epithelium) + microbial biofilms under flow",
      "Physiological/Pathological": "Pathological infection or biofilm formation (oral, lung, device surfaces)",
      "Cell Source": "Host cells (epithelial or fibroblast lines) + microbes (bacteria/fungi), plus relevant media (saliva, etc.)",
      "Multiple Cell Types": "Yes (multi-species microbes + host cells), not typically adding immune cells",
      "Stromal Cells": "No (usually epithelial host only), or co-culture if desired",
      "Tissue-resident Immune": "No (unless specifically introduced)",
      "Circulating Immune": "No, unless user flows immune cells in a custom approach",
      "Crosstalk (Multi-tissue)": "Between host cells and microbes; single-channel design",
      "Air-Liquid Interface": "No, microbes in fluid flow, though partial bridging if simulating mucus on epithelium",
      "Extracellular Matrix": "Host cell monolayer or microbe-secreted biofilm matrix in situ",
      "3D Scaffold": "Biofilms self-assemble in 3D, not a pre-fabricated scaffold",
      "Notable Features": "Grow multi-species biofilm on real host cell surface under shear, test antibiotics or antiseptics",
      "Plate/Format (Throughput)": "BioFlux plates (up to 24–48 channels), moderate throughput",
      "Max Culture Duration": "Hours–days, sometimes multi-day biofilm growth",
      "Readouts - Live Imaging": "Yes, direct microscopy of biofilm development (fluorescent labeling, viability stains)",
      "Readouts - Supernatant Sampling": "Yes (collect effluent to measure bacterial load, pH, secreted factors)",
      "Readouts - Cell Retrieval": "Yes, flush out biofilm or host cells for plating or sequencing",
      "Readouts - Whole Tissue": "In-chip staining or scraping for ex vivo analysis",
      "Readouts - TEER": "No",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "No built-in, rely on imaging and plating assays",
      "Dead Volume": "Low microfluidic volume, 50–200 µL",
      "Perfused": "Yes, continuous flow of media or saliva across cell layer & microbes",
      "Gas Mix Controlled": "Incubator or stage with optional dual gas for anaerobes or partial O₂",
      "Real-time Microenvironment Control": "Flow, media composition, antibiotics introduction, etc.",
      "model_availability": "Commercial product (BioFlux) used for infection/biofilm assays"
    },
    {
      "Company": "Fluxion Biosciences",
      "Model": "IonFlux Automated Patch-Clamp (Electrophysiology)",
      "Organs/Tissues": "Not an organ model, but excitable cells (cardiomyocytes/neurons) in microfluidic patch-clamp system",
      "Physiological/Pathological": "Measures ion channel function, e.g. hERG cardiotoxicity, neuronal excitability",
      "Cell Source": "iPSC-derived cardiomyocytes, neuronal cell lines, or stable cell lines expressing ion channels",
      "Multiple Cell Types": "No, typically single cell type expressing channel of interest",
      "Stromal Cells": "No",
      "Tissue-resident Immune": "No",
      "Circulating Immune": "No",
      "Crosstalk (Multi-tissue)": "No, each well is a patch-clamp site for channel recording",
      "Air-Liquid Interface": "No, cells in solution for patch clamp",
      "Extracellular Matrix": "Minimal; cells can be lightly adherent or in suspension",
      "3D Scaffold": "No, single-cell or small cluster approach",
      "Notable Features": "High-throughput automated voltage clamp recordings for drug-channel interactions, replaces manual patch clamp",
      "Plate/Format (Throughput)": "96- or 384-well IonFlux microfluidic plates, higher throughput for electrophysiology",
      "Max Culture Duration": "Hours for stable recordings, medium-term cell viability in plate",
      "Readouts - Live Imaging": "No; main readout is electrical current traces (patch clamp data)",
      "Readouts - Supernatant Sampling": "Rarely done, main readout is ionic currents",
      "Readouts - Cell Retrieval": "Not typically (cells often lost after patching)",
      "Readouts - Whole Tissue": "N/A",
      "Readouts - TEER": "No",
      "Readouts - MEA": "Not an MEA approach, but direct patch clamp channels",
      "Readouts - Integrated Biosensors": "Yes, integrated microfluidic patch clamp electrodes for electrical signals",
      "Dead Volume": "Low in microfluidic cartridge, fast solution exchange for dose responses",
      "Perfused": "Yes, microfluidic flow of test compounds for rapid solution changes",
      "Gas Mix Controlled": "Usually standard incubator or ambient for short runs",
      "Real-time Microenvironment Control": "Yes, software controls solution exchange, voltage protocols in real time",
      "model_availability": "Commercial product (IonFlux system), user-run"
  }
]
